XML 59 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
QUARTERLY FINANCIAL DATA
 12 Months Ended
Dec. 31, 2012
Quarterly Financial Data [Abstract]  
QUARTERLY FINANCIAL DATA
QUARTERLY FINANCIAL DATA

Selected quarterly financial data for the years ended December 31, 2012 and 2011 is as follows:
 
For the Year Ended December 31, 2012
 
First Quarter (Unaudited)
 
Second Quarter (Unaudited)
 
Third Quarter (Unaudited)
 
Fourth Quarter (Unaudited)
 
(US$ 000's, except per share data)
Consolidated Statements of Operations and Comprehensive Income Data:
 
 
 
 
 
 
 
Net revenues
$
167,433

 
$
211,222

 
$
140,092

 
$
253,338

Cost of revenues
150,408

 
160,507

 
141,332

 
189,267

Operating (loss) / income
(10,303
)
 
23,650

 
(18,401
)
 
(483,139
)
Net (loss) / income
(13,813
)
 
3,141

 
(32,637
)
 
(503,084
)
Net (loss) / income attributable to CME Ltd.
$
(13,392
)
 
$
3,956

 
$
(32,049
)
 
$
(494,195
)
 
 
 
 
 
 
 
 
Net (loss) / income per share:
 
 
 
 
 
 
 
Basic EPS
$
(0.21
)
 
$
0.06

 
$
(0.36
)
 
$
(5.59
)
Effect of dilutive securities
—

 
—

 
—

 
—

Diluted EPS
$
(0.21
)
 
$
0.06

 
$
(0.36
)
 
$
(5.59
)
 
For the Year Ended December 31, 2011
 
First Quarter (Unaudited)
 
Second Quarter (Unaudited)
 
Third Quarter (Unaudited)
 
Fourth Quarter (Unaudited)
 
(US$ 000's, except per share data)
Consolidated Statements of Operations and Comprehensive Income Data:
 
 
 
 
 
 
 
Net revenues
$
172,772

 
$
249,656

 
$
165,472

 
$
276,882

Cost of revenues
150,730

 
179,568

 
150,560

 
188,797

Operating (loss) / income
(7,665
)
 
39,473

 
(12,910
)
 
(12,106
)
Net (loss) / income
(20,995
)
 
812

 
(82,196
)
 
(77,225
)
Net (loss) / income attributable to CME Ltd.
$
(21,114
)
 
$
968

 
$
(82,074
)
 
$
(72,391
)
 
 
 
 
 
 
 
 
Net (loss) / income per share:
 
 
 
 
 
 
 
Basic EPS
$
(0.33
)
 
$
0.02

 
$
(1.27
)
 
$
(1.12
)
Effect of dilutive securities
—

 
—

 
—

 
—

Diluted EPS
$
(0.33
)
 
$
0.02

 
$
(1.27
)
 
$
(1.12
)